ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?

BACKGROUND: The treatment of advanced gastric cancer with curative intent is essentially surgical and chemoradiotherapy is indicated as neo or adjuvant to control the disease and prolong survival. AIM: To assess the survival of patients undergoing subtotal or total gastrectomy with D2 lymphadenectom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arq Bras Cir Dig
Main Authors: ANDREOLLO, Nelson Adami, DRIZLIONOKS, Eric, TERCIOTI-JUNIOR, Valdir, COELHO-NETO, João de Souza, FERRER, José Antonio Possato, CARVALHEIRA, José Barreto Campello, LOPES, Luiz Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: Colégio Brasileiro de Cirurgia Digestiva 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6918727/
https://ncbi.nlm.nih.gov/pubmed/31859917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0102-672020190001e1464
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados